SCHEMBL1063544

SCHEMBL1063544

CCCn1c(=O)c2[nH]c(C)nc2n(CCC)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 1/20 0.68
▸ SIRT3 Q9NTG7 1/20 0.68
▸ SIRT5 Q9NXA8 1/20 0.68
▸ ADORA1 P30542 4/20 0.62
▸ MEN1 O00255 2/20 0.59
▸ CYP1A2 P05177 2/20 0.59
▸ ADORA2A P29274 2/20 0.59
▸ ADORA2B P29275 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ GMNN O75496 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ ADORA3 P0DMS8 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ PMP22 Q01453 1/20 0.59
▸ HIF1A Q16665 1/20 0.59
▸ KDM4E B2RXH2 1/20 0.59
▸ ALDH1A1 P00352 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10856971 0.94 SIRT1 (0.61) SIRT1SIRT3SIRT5ADORA1ADORA2A
SCHEMBL10859893 0.94 SIRT1 (0.61) SIRT1SIRT3SIRT5ADORA1ADORA2A
SCHEMBL7918903 0.90 ADORA1 (0.57) SIRT1SIRT3SIRT5ADORA1ADORA2A
SCHEMBL10855561 0.90 PDE2A (0.73) SIRT1SIRT3SIRT5ADORA1ADORA2A
SCHEMBL9430619 0.90 ADORA2A (0.61) SIRT1SIRT3SIRT5ADORA1MEN1
SCHEMBL9430131 0.89 ADORA2A (0.56) SIRT1SIRT3SIRT5ADORA1MEN1
SCHEMBL11286152 0.88 PDE2A (0.59) SIRT1SIRT3SIRT5ADORA1ADORA2A
SCHEMBL11075794 0.88 SIRT1 (0.54) SIRT1SIRT3SIRT5ADORA1ADORA2A
SCHEMBL9430769 0.88 ADORA2A (0.55) SIRT1SIRT3SIRT5ADORA1MEN1
SCHEMBL10856290 0.87 ADORA2B (0.61) SIRT1SIRT3SIRT5ADORA1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268641-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONIST Advinus Therapeutics Pvt. Ltd. (IN) 2011-01-05 — — EP claimed
WO-2009118759-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONIST ADVINUS THERAPEUTICS PVT. LTD., (IN) 2009-10-01 — — WO claimed
EP-0039780-B1 DI- OR TRISUBSTITUTED XANTHINES WITH NEUROLEPTIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM SOCIETE DES PRODUITS NESTLE S.A. (CH) 1985-04-10 — — EP claimed
US-4469698-A SEDATIVES, TRANQUILIZERS SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) 1984-09-04 — — US claimed
EP-0039780-A1 Di- or trisubstituted xanthines with neuroleptic activity, process for their preparation and pharmaceutical preparations containing them SOCIETE DES PRODUITS NESTLE S.A. (CH) 1981-11-18 — — EP claimed
US-4581451-A ALKYLATION AND CYCLIZATION OF A URACIL COMPOUND NESTEC S.A. (CH) 1986-04-08 — — US disclosed
EP-0039780-B1 DI- OR TRISUBSTITUTED XANTHINES WITH NEUROLEPTIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM SOCIETE DES PRODUITS NESTLE S.A. (CH) 1985-04-10 — — EP disclosed
US-4469698-A SEDATIVES, TRANQUILIZERS SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) 1984-09-04 — — US disclosed
EP-0039780-A1 Di- or trisubstituted xanthines with neuroleptic activity, process for their preparation and pharmaceutical preparations containing them SOCIETE DES PRODUITS NESTLE S.A. (CH) 1981-11-18 — — EP disclosed
Send feedback